The rising cost of development and research is making drug companies turn to each other for help. Rival companies that include Pfizer, AstraZeneca, and Roche plan on sharing clinical data in a standard format. But this isn't the first time we've seen pharmaceutical companies start to share data.
"...Coordinated by the U.S.-based Coalition Against Major Diseases, marks the latest in an intensifying series of research initiatives by industry to override competitive concerns and open up their findings to others as they struggle to reduce costs and boost the speedy launch of medicines."
Read more about this project over at TheStreet: Drug Firms Team on Alzheimer's.
Let's hope we start to see more collaboration for a cure--solving the world's biggest problems the open source way.
Thanks to Mike Esser for sending TheStreet article our way.
See a similar article posted on WSJ.com Drug Makers Share Data From Failed Trials.